A Phase I Relative Bioavailability Study To Compare The Powder-In-Capsule And Immediate Release Tablet Of PF-02341066 In Healthy Volunteers.
Phase of Trial: Phase I
Latest Information Update: 20 Oct 2011
At a glance
- Drugs Crizotinib (Primary)
- Indications Neuroblastoma; Non-small cell lung cancer; Solid tumours
- Focus Pharmacokinetics
- 09 Sep 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 25 Jul 2009 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 21 Jul 2009 New trial record